New Mexico AG Presses Feds Over Fentanyl Records
Attorney General Raúl Torrez, speaking at an Albuquerque Journal panel, said federal investigations allowed fentanyl to reach New Mexico communities.
Updated on Nov. 18, 2026 in Substance Abuse

Live Poll
Do you trust federal agencies to keep fentanyl out of your community?
New Mexico Attorney General Raúl Torrez discussed the state's fentanyl response at a panel hosted at the Albuquerque Journal's Ray Cary Auditorium. Torrez said federal authorities allowed large quantities of fentanyl to reach Albuquerque and other communities during long-term drug investigations.
Why it matters
The dispute over federal disclosure records bears directly on how New Mexico understands the source and spread of fentanyl within its borders. The outcome could shape how state and federal agencies coordinate enforcement and treatment responses.
Albuquerque Police Department spokesperson Gilbert Gallegos said single pills can cost less than $1 and large quantities up to $200-300. The total volume of fentanyl that federal agents failed to recover in New Mexico has not been disclosed.
The players
Raúl Torrez
Torrez is the New Mexico Attorney General, leading the state's legal challenge over federal fentanyl disclosure records.
Drug Enforcement Administration
The DEA is the federal agency responsible for enforcing U.S. drug laws, and its New Mexico actions are now under congressional investigation.
The details
Torrez said his office attempted to obtain disclosure records from the Department of Justice before filing a lawsuit. The U.S. House Oversight Committee has opened an investigation into DEA actions in New Mexico, and a federal judge is expected to rule on the suit within months.
Timeline
Days after the lawsuit was filed, the U.S. House Oversight Committee opened an investigation into DEA actions in New Mexico.
A federal judge is expected to decide the lawsuit within a few more months.
Big Picture
The state's lawsuit runs parallel to the U.S. House Oversight Committee's investigation into DEA actions in New Mexico, pursuing the same federal records through the courts.
Residents of New Mexico may see changes in how federal and state agencies share enforcement information on fentanyl. Treatment options for fentanyl addiction, including injectable long-acting opioids, methadone and buprenorphine, remain available through providers.
The takeaway
Fentanyl's low cost and widespread availability make it a persistent public-safety concern, and treatment access remains central to the state's response. Readers seeking treatment options should consult a licensed provider.
What happens next
A federal judge is expected to rule on the New Mexico attorney general's lawsuit seeking DEA disclosure records within a few months.
Further reading
For more on the state's approach, see Substance Abuse coverage across New Mexico.
Source note: This article includes information reported by Abqjournal.
Live Poll
Do you trust federal agencies to keep fentanyl out of your community?










